Skip to content

Oestrogen may block HIV reactivation, hints at gender differences in viral reservoirs

Jonathan Karn at IAS 2015. Photo © Marcus Rose/IAS 2015.

HIV treatment as prevention scale-up linked to reduced mortality among people who inject drugs in Vancouver

HIV-positive youth are less likely than adults to achieve viral suppression on antiretroviral treatment

Good outcomes for people living with HIV diagnosed with Hodgkin's lymphoma in France

HIV-treatment 'booster drugs' are most likely to have dangerous interactions with methamphetamine, mephedrone, MDMA and ketamine

HIV-positive postpartum women who rapidly re-engage with HIV care more likely to have viral suppression in longer term

People with HIV and hepatitis B co-infection can safely switch to simpler TAF single-tablet regimen

Study sheds light on how tenofovir is processed in different body tissues

Third of people with HIV who use drugs intentionally miss doses of HIV treatment when planning to use drugs